Preface to the Third Edition |
|
vii | |
Preface to the Second Edition |
|
ix | |
Preface to the First Edition |
|
xi | |
|
Part One Fundamentals of Genetic Processes |
|
|
|
|
3 | (10) |
|
1.1 What Is DNA and What Is a Gene? |
|
|
3 | (1) |
|
1.2 What Is Gene Cloning? |
|
|
4 | (1) |
|
|
5 | (1) |
|
1.4 Heredity Factors and Traits |
|
|
6 | (2) |
|
|
8 | (1) |
|
1.6 Relating Genes to Inherited Traits |
|
|
9 | (1) |
|
|
10 | (3) |
|
2 Structures of Nucleic Acids |
|
|
13 | (8) |
|
|
13 | (1) |
|
2.2 Purine and Pyrimidine Bases |
|
|
14 | (1) |
|
2.3 Complementary Base Pairing |
|
|
15 | (1) |
|
2.4 Writing a DNA Molecule |
|
|
16 | (1) |
|
|
17 | (1) |
|
2.6 Denaturation and Renaturation |
|
|
17 | (1) |
|
|
18 | (3) |
|
|
21 | (8) |
|
|
21 | (1) |
|
|
22 | (2) |
|
3.3 Structural Organization |
|
|
24 | (1) |
|
3.4 Posttranslational Modification |
|
|
25 | (1) |
|
|
26 | (3) |
|
|
29 | (10) |
|
4.1 From Genes to Proteins |
|
|
29 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
31 | (1) |
|
4.5 Why Present a Sequence Using the Coding Strand? |
|
|
32 | (1) |
|
|
33 | (2) |
|
|
35 | (1) |
|
4.8 The Replicon and Replication Origin |
|
|
36 | (1) |
|
4.9 Relating Replication to Gene Cloning |
|
|
37 | (2) |
|
|
39 | (14) |
|
|
39 | (1) |
|
5.2 Control of Transcription |
|
|
40 | (4) |
|
5.2.1 Where Are the Transcription Start Site and Termination Site? |
|
|
40 | (2) |
|
5.2.2 When Does Transcription Start or Stop? |
|
|
42 | (2) |
|
5.3 Control of Translation |
|
|
44 | (1) |
|
5.3.1 Ribosome Binding Site and Start Codon |
|
|
44 | (1) |
|
5.3.2 Translation Termination Site |
|
|
44 | (1) |
|
5.4 The Tryptophan Operon |
|
|
44 | (3) |
|
|
45 | (1) |
|
|
45 | (2) |
|
|
47 | (1) |
|
5.5 The Control System in Eukaryotic Cells |
|
|
47 | (6) |
|
5.5.1 Transcriptional Control |
|
|
48 | (1) |
|
|
48 | (1) |
|
5.5.3 Capping and Tailing |
|
|
49 | (1) |
|
5.5.4 Ribosome Binding Sequence |
|
|
50 | (1) |
|
5.5.5 Monocistronic and Polycistronic |
|
|
50 | (3) |
|
6 Reading the Nucleotide Sequence of a Gene |
|
|
53 | (14) |
|
|
53 | (2) |
|
|
55 | (12) |
|
6.2.1 Reading the Genomic Sequence |
|
|
59 | (1) |
|
6.2.2 Reading the cDNA Sequence |
|
|
60 | (7) |
|
Part Two Techniques and Strategies of Gene Cloning |
|
|
|
7 Enzymes Used in Cloning |
|
|
67 | (8) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (4) |
|
7.3.1 E. coli DNA Polymerase I |
|
|
69 | (2) |
|
7.3.2 Bacteriophage T4 and T7 Polymerase |
|
|
71 | (1) |
|
7.3.3 Reverse Transcriptase |
|
|
72 | (1) |
|
7.4 Phosphatase and Kinase |
|
|
72 | (3) |
|
8 Techniques Used in Cloning |
|
|
75 | (18) |
|
|
75 | (1) |
|
|
75 | (3) |
|
8.2.1 Agarose Gel Electrophoresis |
|
|
76 | (1) |
|
8.2.2 Polyacrylamide Gel Electrophoresis |
|
|
76 | (2) |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
78 | (2) |
|
|
80 | (2) |
|
|
82 | (1) |
|
8.8 Immunological Techniques |
|
|
82 | (2) |
|
|
84 | (3) |
|
8.10 Polymerase Chain Reaction |
|
|
87 | (1) |
|
8.11 Site-Directed Mutagenesis |
|
|
88 | (3) |
|
8.12 Non-radioactive Detection Methods |
|
|
91 | (2) |
|
9 Cloning Vectors for Introducing Genes into Host Cells |
|
|
93 | (30) |
|
9.1 Vectors for Bacterial Cells |
|
|
93 | (11) |
|
|
93 | (6) |
|
9.1.2 Bacteriophage Vectors |
|
|
99 | (3) |
|
|
102 | (1) |
|
|
103 | (1) |
|
9.2 Yeast Cloning Vectors |
|
|
104 | (2) |
|
|
104 | (2) |
|
9.2.2 The Pichia pastoris Expression Vectors |
|
|
106 | (1) |
|
9.3 Vectors for Plant Cells |
|
|
106 | (6) |
|
9.3.1 Binary Vector System |
|
|
107 | (2) |
|
9.3.2 Cointegrative Vector System |
|
|
109 | (1) |
|
|
109 | (3) |
|
9.3.4 Plant Specific Promoters |
|
|
112 | (1) |
|
9.4 Vectors for Mammalian Cells |
|
|
112 | (11) |
|
|
113 | (1) |
|
9.4.2 Direct DNA Transfer |
|
|
114 | (1) |
|
|
115 | (4) |
|
|
119 | (4) |
|
10 Gene-Vector Construction |
|
|
123 | (8) |
|
10.1 Cloning or Expression |
|
|
123 | (1) |
|
10.2 The Basic Components |
|
|
123 | (2) |
|
10.2.1 Expression Vectors |
|
|
124 | (1) |
|
10.3 Reading a Vector Map |
|
|
125 | (1) |
|
10.4 The Cloning/Expression Region |
|
|
125 | (2) |
|
10.5 The Gene Must Ligate in Frame with the Vector for Expression |
|
|
127 | (1) |
|
10.6 Linkers and Adapters for Introducing Restriction Sites |
|
|
128 | (3) |
|
|
131 | (6) |
|
11.1 Calcium Salt Treatment |
|
|
131 | (1) |
|
|
132 | (1) |
|
11.3 Agrobacterium Infection |
|
|
132 | (1) |
|
11.4 The Biolistic Process |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
133 | (1) |
|
|
134 | (1) |
|
11.8 Cell-Free Expression |
|
|
134 | (3) |
|
12 Isolating Genes for Cloning |
|
|
137 | (6) |
|
|
137 | (1) |
|
|
138 | (2) |
|
12.3 Choosing the Right Cell Types for mRNA Isolation |
|
|
140 | (3) |
|
Part Three Impact of Gene Cloning: Applications in Agriculture |
|
|
|
13 Improving Tomato Quality by Antisense RNA |
|
|
143 | (6) |
|
|
143 | (2) |
|
13.2 A Strategy for Engineering Tomatoes with Antisense RNA |
|
|
145 | (4) |
|
14 Transgenic Crops Engineered with Insecticidal Activity |
|
|
149 | (4) |
|
14.1 Bacillus thuringiensis Toxins |
|
|
149 | (1) |
|
14.2 Cloning of the cry Gene into Cotton Plants |
|
|
150 | (3) |
|
14.2.1 Modifying the cry Gene |
|
|
150 | (1) |
|
14.2.2 The Intermediate Vector |
|
|
150 | (1) |
|
14.2.3 Transformation by Agrobacterium |
|
|
150 | (3) |
|
15 Transgenic Crops Conferred with Herbicide Resistance |
|
|
153 | (4) |
|
|
153 | (2) |
|
15.2 Cloning of the aroA gene |
|
|
155 | (2) |
|
16 Growth Enhancement in Transgenic Fish |
|
|
157 | (6) |
|
16.1 Gene Transfer in Fish |
|
|
157 | (1) |
|
16.2 Cloning Salmons with a Chimeric Growth Hormone Gene |
|
|
158 | (5) |
|
Part Four Impact of Gene Cloning: Applications in Medicine and Related Areas |
|
|
|
17 Microbial Production of Recombinant Human Insulin |
|
|
163 | (4) |
|
17.1 Structure and Action of Insulin |
|
|
163 | (1) |
|
17.2 Cloning Human Insulin Gene |
|
|
164 | (3) |
|
18 Finding Disease-Causing Genes |
|
|
167 | (10) |
|
|
167 | (2) |
|
18.1.1 Frequency of Recombination |
|
|
168 | (1) |
|
|
169 | (1) |
|
|
169 | (3) |
|
18.2.1 Chromosome Walking |
|
|
170 | (1) |
|
18.2.2 Chromosome Jumping |
|
|
171 | (1) |
|
18.2.3 Yeast Artificial Chromosome |
|
|
171 | (1) |
|
|
172 | (1) |
|
18.4 Isolation of the Mouse Obese Gene |
|
|
173 | (1) |
|
|
173 | (4) |
|
18.5.1 Targeted Enrichment by Sequence Capture |
|
|
174 | (1) |
|
18.5.2 Disease Gene Identification |
|
|
175 | (2) |
|
|
177 | (10) |
|
19.1 Physical and Chemical Methods |
|
|
177 | (2) |
|
|
179 | (2) |
|
19.2.1 Life Cycle of Retroviruses |
|
|
179 | (1) |
|
19.2.2 Construction of a Safe Retrovirus Vector |
|
|
179 | (1) |
|
19.2.3 Gene Treatment of Severe Combined Immune Deficiency |
|
|
180 | (1) |
|
19.3 Adeno-Associated Virus |
|
|
181 | (3) |
|
19.3.1 Life Cycle of Adeno-Associated Virus |
|
|
182 | (1) |
|
19.3.2 Recombinant Adeno-Associated Virus |
|
|
182 | (2) |
|
19.3.3 Recombinant Adeno-Associated Virus-Mediated Gene Treatment for Leber's Congenital Amaurosis Type 2 |
|
|
184 | (1) |
|
19.4 Therapeutic Vaccines |
|
|
184 | (3) |
|
19.4.1 Construction of DNA Vaccines |
|
|
185 | (1) |
|
19.4.2 Delivery of DNA Vaccines |
|
|
185 | (2) |
|
20 Gene Targeting and Genome Editing |
|
|
187 | (12) |
|
|
187 | (1) |
|
20.2 Replacement Targeting Vectors |
|
|
188 | (1) |
|
20.3 Gene Targeting Without Selectable Markers |
|
|
189 | (3) |
|
|
190 | (1) |
|
20.3.2 The Double-Hit Method |
|
|
190 | (1) |
|
20.3.3 The Cre/loxP Recombination |
|
|
191 | (1) |
|
20.4 Gene Targeting for Xenotransplants |
|
|
192 | (1) |
|
20.5 Engineered Nucleases: ZFN, TALEN, CRISPR |
|
|
193 | (6) |
|
20.5.1 Zinc-Finger Nucleases |
|
|
194 | (1) |
|
20.5.2 Transcription Activator-Like Effector Nucleases |
|
|
194 | (1) |
|
20.5.3 The CRISPR/Cas System |
|
|
195 | (1) |
|
20.5.4 Nonhomologous End Joining and Homology-Directed Repair |
|
|
196 | (1) |
|
20.5.5 Expressing Engineered Nucleases in Target Cells |
|
|
196 | (3) |
|
|
199 | (10) |
|
21.1 Variable Number Tandem Repeats |
|
|
199 | (1) |
|
21.2 Polymorphism Analysis Using VNTR Markers |
|
|
200 | (1) |
|
21.3 Single-Locus and Multi-locus Probes |
|
|
201 | (1) |
|
21.4 Paternity Case Analysis |
|
|
201 | (1) |
|
21.5 Short Tandem Repeat Markers |
|
|
202 | (3) |
|
21.5.1 The Combined DNA Index System |
|
|
204 | (1) |
|
21.6 Mitochondrial DNA Sequence Analysis |
|
|
205 | (4) |
|
22 Transpharmers: Bioreactors for Pharmaceutical Products |
|
|
209 | (4) |
|
22.1 General Procedure for Production of Transgenic Animals |
|
|
210 | (1) |
|
22.2 Transgenic Sheep for arAntitrypsin |
|
|
210 | (3) |
|
|
213 | (6) |
|
23.1 Cell Differentiation |
|
|
213 | (1) |
|
|
214 | (1) |
|
23.3 The Cloning of Dolly |
|
|
215 | (1) |
|
23.4 Gene Transfer for Farm Animals |
|
|
216 | (3) |
|
24 Whole Genome and Next Generation Sequencing |
|
|
219 | (12) |
|
|
219 | (2) |
|
|
220 | (1) |
|
|
220 | (1) |
|
|
221 | (3) |
|
24.2.1 Sequence Tagged Sites |
|
|
221 | (1) |
|
24.2.2 Radiation Hybridization |
|
|
221 | (1) |
|
|
222 | (1) |
|
24.2.4 The Bacterial Artificial Chromosome Vector |
|
|
223 | (1) |
|
24.3 Comprehensive Integrated Maps |
|
|
224 | (1) |
|
24.4 Strategies For Genome Sequencing |
|
|
224 | (2) |
|
24.4.1 Hierarchical Shotgun Sequencing |
|
|
224 | (2) |
|
24.4.2 Whole-Genome Shotgun Sequencing |
|
|
226 | (1) |
|
24.5 Next Generation Sequencing of Whole Genomes |
|
|
226 | (5) |
|
24.5.1 The Basic Scheme of NGS |
|
|
227 | (4) |
Suggested Readings |
|
231 | (14) |
Index |
|
245 | |